Shu B. Wang

197 Ruijin 2nd Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Single-Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease.

Single-Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 09, 2025

Significance of Thyroid-Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves Disease.

Significance of Thyroid-Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves Disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 29, 2024

Techno-economic and scalability analysis of nitrogen plasma gasification of medical waste.

Techno-economic and scalability analysis of nitrogen plasma gasification of medical waste.

Journal: Waste management (New York, N.Y.)

Published: May 20, 2024

Effects of Low-dose Methotrexate With Methimazole in Patients With Graves' Disease: Results of a Randomized Clinical Trial.

Effects of Low-dose Methotrexate With Methimazole in Patients With Graves' Disease: Results of a Randomized Clinical Trial.

Journal: The Journal of clinical endocrinology and metabolism

Published: March 29, 2024

Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves' orbitopathy.

Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves' orbitopathy.

Journal: European thyroid journal

Published: July 17, 2022

The CD14++CD16+ monocyte subset is expanded and controls Th1 cell development in Graves' disease.

The CD14++CD16+ monocyte subset is expanded and controls Th1 cell development in Graves' disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: June 14, 2022

The role of activated monocyte IFN/SIGLEC1 signalling in Graves' disease.

The role of activated monocyte IFN/SIGLEC1 signalling in Graves' disease.

Journal: The Journal of endocrinology

Published: May 30, 2022

Collaborative Ring Trial of the Applicability of a Reference Plasmid DNA Calibrant in the Quantitative Analysis of GM Maize Event MON810.

Collaborative Ring Trial of the Applicability of a Reference Plasmid DNA Calibrant in the Quantitative Analysis of GM Maize Event MON810.

Journal: Foods (Basel, Switzerland)

Published: April 04, 2022

The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves' disease.

The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves' disease.

Journal: Therapeutic advances in endocrinology and metabolism

Published: April 11, 2021

lncRNA:mRNA expression profile in CD4+ T cells from patients with Graves' disease.

lncRNA:mRNA expression profile in CD4+ T cells from patients with Graves' disease.

Journal: Endocrine connections

Published: September 29, 2020

Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease.

Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease.

Journal: Scientific reports

Published: July 27, 2020

Decreased SIRT1 expression in the peripheral blood of patients with Graves' disease.

Decreased SIRT1 expression in the peripheral blood of patients with Graves' disease.

Journal: The Journal of endocrinology

Published: May 13, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026